Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Unichem Laboratories LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:506690NSE Symbol: UNICHEMLABP/E(TTM):0
ISIN Demat:INE351A01035Div & Yield %:0.67EPS(TTM):0
Book Value(Rs):332.0010297Market Cap ( Cr.):4173.65Face Value(Rs):2
    Change Company 
( In Cr)
 Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
INCOME :      
Sales Turnover 1072.43942.931123.97904.44967.74666.47
Excise Duty0.000.000.000.000.000.39
Net Sales1072.43942.931123.97904.44967.74666.08
Other Income 41.8542.0747.3799.17103.302740.89
Stock Adjustments -22.0152.7916.7318.5030.54-4.70
Total Income1092.271037.791188.071022.111101.583402.27
EXPENDITURE :      
Raw Materials 501.86436.27449.67401.25443.38345.98
Power & Fuel Cost101.4177.1267.9572.1475.4348.26
Employee Cost 270.86250.79234.04205.16176.76146.54
Other Manufacturing Expenses 70.6173.4964.4868.0962.5739.38
Selling and Administration Expenses 194.89192.65225.80263.43281.65207.29
Miscellaneous Expenses 116.368.953.283.4819.2910.15
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure1256.001039.271045.231013.551059.07797.60
Operating Profit-163.73-1.49142.848.5642.512604.67
Interest 9.382.071.301.280.623.17
Gross Profit-173.11-3.56141.547.2841.892601.50
Depreciation105.9883.1975.8971.0961.7145.04
Profit Before Tax-279.09-86.7565.65-63.81-19.822556.46
Tax0.000.000.000.00-1.24-12.72
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax20.61-31.3211.56-7.50-27.3812.58
Reported Net Profit-299.70-55.4354.08-56.328.802556.60
Extraordinary Items -103.16-0.250.02-1.45-9.09-4.06
Adjusted Net Profit-196.54-55.1854.06-54.8717.892560.66
Adjst. below Net Profit 121.810.000.000.00-7.23-624.52
P & L Balance brought forward2565.362648.962623.042712.212745.81844.48
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 28.1628.1628.1632.8535.1730.76
P & L Balance carried down2359.312565.362648.962623.042712.212745.81
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %200.00200.00200.00200.00200.00250.00
Earnings Per Share-Unit Curr-42.57-7.877.68-8.001.25363.48
Earnings Per Share(Adj)-Unit Curr-42.57-7.877.68-8.001.25363.48
Book Value-Unit Curr338.65379.52383.11375.99388.15392.63